BioXcel Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • BioXcel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was -$199K, a 106% decline year-over-year.
  • BioXcel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $6.16M, a 66.9% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.16M, a 66.9% decline from 2023.
  • BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.6M, a 7.37% increase from 2022.
  • BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.3M, a 10.9% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.16M -$12.5M -66.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $18.6M +$1.28M +7.37% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $17.3M -$2.12M -10.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $19.5M +$4.84M +33.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $14.6M +$11.5M +365% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $3.14M +$60K +1.95% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $3.08M +$1.48M +91.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $1.61M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.